Lek planning EUR 83m investment in Ljubljana

Ljubljana – Lek, a Novartis-owned Slovenian drug maker, is planning an EUR 82.6 million investment in Ljubljana to set up a new production facility for liquid vials and pre-filled syringes. The government is expected to subsidise it with EUR 6.56 million, according to working documents prepared for government sessions. Construction of the Production of Aseptic Products – Facility 70 in Verovškova Street, Lek’s main site in the capital, is planned to start in October and is slated for completion in October 2024. The investment will create around 120 jobs. It…

For FREE further reading please JUST enter your email address


I allow to collect my email data for analytics and email campaign